Eldorin Capsule (Erdosteine)

Adult dose

Adults: Administer 300 mg of erdosteine orally (take) 2–3 times a day. When administered for acute respiratory conditions, do not use continuously for more than 10 days.

This medication should not be used by individuals who have an allergic reaction to this medication or its components. Patients with cirrhosis or those with certain enzyme deficiencies should not take this medication, as its metabolites may be harmful. Patients with peptic ulcers should also avoid this medication. Patients with severely impaired kidney function, specifically those with a creatinine clearance of less than 25 mL/min, should not use this medication. Patients with severely compromised liver function should not take this medication. Patients with slightly impaired liver function should be cautious and not exceed 300 mg per day when using this medication. Diabetic patients or those on a calorie-restricted diet should take caution when using the syrup formulation of this medication. This medication contains the dye Yellow No. 5, so individuals who are allergic or sensitive to this component should use it cautiously. Overdose may cause excessive sweating, dizziness, flushing of the face. Neurological and respiratory symptoms such as headache, cold symptoms, difficulty breathing may occur. Gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, and heartburn may also be experienced. Allergic reactions such as hives, red spots, eczema may occur on the skin. After taking this medication, symptoms such as fatigue, indigestion, swelling of the face or body, itching, lethargy, drowsiness, and rash have been reported, although direct correlation with this medication is not confirmed. Taking this medication with cough medicines may make it difficult to expel phlegm and increase the risk of bronchial infection or bronchoconstriction, so caution is necessary. It is recommended that pregnant women, women who may become pregnant, and breastfeeding women not use this medication as its safety has not been sufficiently established. This medication should be kept out of reach of children, and transferring it to another container may lead to accidents or compromise the quality of the medication.

• sweating
• dizziness
• flushing
• headache
• cold
• dyspnea
• altered taste
• nausea
• vomiting
• diarrhea

Drug interactions

This medication should be taken with cough medicines only after consulting a physician or pharmacist.

This medication may be sensitive to air and moisture, so it must be stored in a sealed container. Additionally, it is advisable to keep it at room temperature, between 1 degree and 30 degrees Celsius, and not in areas that are too hot or too cold. Storing it this way will help maintain its efficacy for a long time.

Appearance

Green hard capsule with upper part filled with white to off-white powder or granules and lower part in pale yellow

Package unit

30 capsules/bottle, 300 capsules/bottle